MME and heart failure: Inhibition of neprilysin increases levels of ANP, BNP, C-type natriuretic peptide (CNP) and bradykinin, which leads to vasodilation and decreases systolic blood and pulse pressure; furthermore, it has been shown to reduce mortality in heart failure patients (the Paradigm study [18]).